FDA approves another new type of opioid overdose antidote nasal spray

Zachary Brennan

Senior Editor

As more than 100,000 Americans continue to die every year from the opioid overdose epidemic, the FDA late Monday approved another new nasal spray that …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

FDA approves another new type of opioid overdose antidote nasal spray

Zachary Brennan

Senior Editor

Sign up to read this article for free.

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

China’s biotech market is staging a comeback that US biotech can only wish for

With aims to become a 'generational biotech,' Zealand Pharma hires Lilly veteran as science chief

Large vaccine makers stand by their investments despite US headwinds

Genentech vet launches ADC startup with $20M

Makary, in one of first comments on FDA policy, floats new pathway for rare disease drugs

ADSTILADRIN® (nadofaragene firadenovec-vncg) – A Growing Body of Clinical Data and Real-World Evidence

FDA ap­proves an­oth­er new type of opi­oid over­dose an­ti­dote nasal spray

Senior Editor

Sign up to read this article for free.

Autonomy Bio Inc.

San Francisco, CA 94107, USA

FDA approves another new type of opioid overdose antidote nasal spray